Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01868022
Title Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated Fibroblast Growth Factor (FGF) Pathway Signaling
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: adult
Covered Countries USA | NLD | GBR | ESP | BEL

Facility Status City State Zip Country Details
GSK Investigational Site Duarte California 91010 United States Details
GSK Investigational Site Sacramento California 95817 United States Details
GSK Investigational Site Chicago Illinois 60637 United States Details
GSK Investigational Site Peoria Illinois 61615-7822 United States Details
GSK Investigational Site Detroit Michigan 48201 United States Details
GSK Investigational Site Saint Louis Missouri 63110 United States Details
GSK Investigational Site New York New York 10065 United States Details
GSK Investigational Site Chapel Hill North Carolina 27599-7600 United States Details
GSK Investigational Site Columbus Ohio 43210 United States Details
GSK Investigational Site Charleston South Carolina 29425 United States Details
GSK Investigational Site Leuven 3000 Belgium Details
GSK Investigational Site Koebenhavn Oe 2100 Denmark Details
GSK Investigational Site Amsterdam 1066 CX Netherlands Details
GSK Investigational Site Arkhangelsk 163045 Russian Federation Details
GSK Investigational Site Ryazan 390011 Russian Federation Details
GSK Investigational Site St. Petersburg 197 089 Russian Federation Details
GSK Investigational Site St. Petersburg 197758 Russian Federation Details
GSK Investigational Site St. Petersburg 198255 Russian Federation Details
GSK Investigational Site Vsevolozhsk 188663 Russian Federation Details
GSK Investigational Site Badajoz 06080 Spain Details
GSK Investigational Site Barcelona 08028 Spain Details
GSK Investigational Site Barcelona 08035 Spain Details
GSK Investigational Site Madrid 28034 Spain Details
GSK Investigational Site Madrid 28040 Spain Details
GSK Investigational Site Málaga 29010 Spain Details
GSK Investigational Site Sevilla 41013 Spain Details
GSK Investigational Site Leicester Leicestershire LE1 5WW United Kingdom Details
GSK Investigational Site London SE1 9RT United Kingdom Details
GSK Investigational Site Nottingham NG5 1PB United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field